Purchases and Sales Made in Q4 2024 in Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO) during Q4 2024. The information is specifically focused on institutions that hold shares of Allogene Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Creative Planning
Overland Park, KS |
SELL
|
- |
-7.85K- 12.79% |
$14.4K - $25.3K
|
53.5K
$109K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-7.87K- 72.93% |
$14.5K - $25.3K
|
2.92K
$5.96K
|
|
Feb 14, 2025
Q4 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-10.8K- 66.82% |
$19.9K - $34.8K
|
5.36K
$10.9K
|
|
Feb 13, 2025
Q4 2024
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-15.1K- 28.46% |
$27.8K - $48.7K
|
38K
$77.6K
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-15.2K- 11.91% |
$27.9K - $48.9K
|
112K
$229K
|
|
Feb 07, 2025
Q4 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-17.5K- 59.02% |
$32.2K - $56.4K
|
12.2K
$24.8K
|
|
Jan 17, 2025
Q4 2024
|
Bourgeon Capital Management LLC
|
SELL
|
- |
-23.9K- 16.75% |
$43.9K - $76.9K
|
119K
$242K
|
|
Feb 14, 2025
Q4 2024
|
Caxton Associates LP
New York, NY |
SELL
|
- |
-35.7K- 14.75% |
$65.7K - $115K
|
206K
$421K
|
|
Feb 13, 2025
Q4 2024
|
Zacks Investment Management
Chicago, IL |
SELL
|
- |
-35.7K- 6.92% |
$65.7K - $115K
|
481K
$981K
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-35.8K- 39.64% |
$65.9K - $115K
|
54.5K
$111K
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-42K- 10.04% |
$77.3K - $135K
|
377K
$768K
|
|
Feb 13, 2025
Q4 2024
|
Cerity Partners LLC
New York, NY |
SELL
|
- |
-45K- 10.41% |
$82.8K - $145K
|
387K
$790K
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-56K- 2.59% |
$103K - $180K
|
2.11M
$4.3M
|
|
Feb 14, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-62.6K- 90.51% |
$115K - $202K
|
6.56K
$13.4K
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-85.8K- 3.07% |
$158K - $276K
|
2.71M
$5.53M
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-87.5K- 13.62% |
$161K - $282K
|
555K
$1.13M
|
|
Feb 11, 2025
Q4 2024
|
Td Asset Management Inc
|
SELL
|
- |
-132K- 19.46% |
$242K - $424K
|
545K
$1.11M
|
|
Jan 31, 2025
Q4 2024
|
Partners Capital Investment Group, LLP
Boston, MA |
SELL
|
- |
-162K- 63.41% |
$297K - $520K
|
93.2K
$190K
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-168K- 89.21% |
$309K - $541K
|
20.3K
$41.5K
|
|
Feb 14, 2025
Q4 2024
|
Coastal Bridge Advisors, LLC
|
SELL
|
- |
-185K- 45.53% |
$340K - $595K
|
221K
$451K
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-273K- 62.41% |
$503K - $880K
|
165K
$336K
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-327K- 3.93% |
$602K - $1.05M
|
8M
$16.3M
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-351K- 8.6% |
$647K - $1.13M
|
3.74M
$7.62M
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-353K- 7.3% |
$650K - $1.14M
|
4.49M
$9.15M
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-723K- 41.99% |
$1.33M - $2.33M
|
999K
$2.04M
|
|
Feb 10, 2025
Q4 2024
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-741K- 13.07% |
$1.36M - $2.39M
|
4.93M
$10.1M
|